Cargando…
Clinically accurate diagnosis of Alzheimer’s disease via multiplexed sensing of core biomarkers in human plasma
Alzheimer’s disease (AD) is the most prevalent neurodegenerative disorder, affecting one in ten people aged over 65 years. Despite the severity of the disease, early diagnosis of AD is still challenging due to the low accuracy or high cost of neuropsychological tests and neuroimaging. Here we report...
Autores principales: | Kim, Kayoung, Kim, Min-Ji, Kim, Da Won, Kim, Su Yeong, Park, Steve, Park, Chan Beum |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6949261/ https://www.ncbi.nlm.nih.gov/pubmed/31913282 http://dx.doi.org/10.1038/s41467-019-13901-z |
Ejemplares similares
-
Plasma contact factors as novel biomarkers for diagnosing Alzheimer’s disease
por: Park, Jung Eun, et al.
Publicado: (2021) -
Integration of amyloid-β oligomerization tendency as a plasma biomarker in Alzheimer's disease diagnosis
por: Pyun, Jung-Min, et al.
Publicado: (2023) -
Serum Biomarkers for the Diagnosis of Glaucoma
por: Shin, Young Joo, et al.
Publicado: (2020) -
Multiplexed plasma protein classifiers for the diagnosis of age‐related macular degeneration
por: Ahn, Hee‐Sung, et al.
Publicado: (2023) -
Plasma metabolites as possible biomarkers for diagnosis of breast cancer
por: Park, Jiwon, et al.
Publicado: (2019)